(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NAVXPRESS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NAVXPRESS

ST13

US500000097436697

Class

40, 42

Filing

97436697

Registration

7566017

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

12/17/2024

Trademark type

Word

Nice classes

40, 42

Filing date

05/31/2022

Registration date

11/12/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/12/2024

Last transaction

12/17/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/09/2022

First use in commerce

03/14/2023

Drawing code

4

Owner type

03

Owner location

Rockville, MD, US

Examiner

QUILICI, BRENDAN A

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

REGENXBIO Inc.

Representatives

William R. Samuels COLE-FRIEMAN & MALLON LLP

Technical classification

Nice Classes

Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Custom manufacture of reagents for scientific and medical research and development; Custom manufacturing servicesproduction for others of clinical and medical reagents for use in gene therapyfor development of pharmaceutical preparations for use in gene therapyof therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapyincluding gene therapy delivery of antibody biologicsenzymes and RNA interference (RNAi)

Class 42

Custom design and development of reagents for scientific and medical research and development

Publications

History of USPTO decisions and trademark events.

41 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/12/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/12/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/12/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/12/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/08/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/29/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/29/2024

ALIE

ASSIGNED TO LIE

08/29/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/28/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

12/28/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

12/28/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/29/2023

GNRT

NON-FINAL ACTION E-MAILED

09/29/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

09/29/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/26/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/26/2023

IUAF

USE AMENDMENT FILED

08/21/2023

EISU

TEAS STATEMENT OF USE RECEIVED

08/21/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/17/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/17/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/17/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/09/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/14/2023

PUBO

PUBLISHED FOR OPPOSITION

03/14/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/22/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/07/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

02/06/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/06/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

02/06/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/06/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/25/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/25/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/25/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/06/2022

GNRT

NON-FINAL ACTION E-MAILED

09/06/2022

CNRT

NON-FINAL ACTION WRITTEN

09/06/2022

DOCK

ASSIGNED TO EXAMINER

08/25/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/08/2022

NWAP

NEW APPLICATION ENTERED

06/03/2022

Continuous trademark protection

Get notified about every new filing that threatens NAVXPRESS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.